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A 69-year-old Caucasian man presented with acute renal
failure and ‘sand in the urine.’ A review of systems was
positive for anorexia, nausea, vomiting, decreased urine
output, and vague lower abdominal discomfort. His medical
history was remarkable for non-Hodgkin’s lymphoma treated
with chemotherapy and cerebral toxoplasmosis diagnosed 4
months prior. The patient was taking pyrimethamine 75 mg
daily, sulfadiazine 1.5 g every 6 h, and leucovorin 20 mg daily.
His blood pressure was 161/85 and pulse 95/min. His serum
creatinine level was 3.5 mg/dl (309 mmol/l); blood urea
nitrogen 30 mg/dl (10.7 mmol/l); sodium 135 mmol/l; potas-
sium 5.2 mmol/l; chloride 98 mmol/l; bicarbonate 25 mmol/l;
calcium 11.1 mEq/l (2.77 mmol/l); phosphorus 5.5 mg/dl
(1.78 mmol/l); albumin 3.9 g/dl (39 g/l). His hematocrit value
was 35.1%; white blood cell count was 7.600 109/l.
Urinalysis showed specific gravity of 1.012, pH 5.0, no
protein and 210 red blood cells per high-power field. Patient
had the following imaging studies performed: computed
tomography of the abdomen (Figure 1) and antegrade
pyelogram (Figure 2).
What is your clinical diagnosis?
What medical and surgical interventions would be helpful
in the management of this patient?
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Figure 1 | A reconstructed abdominal computed tomography of
the abdomen and pelvis.
Figure 2 | A bilateral antegrade pyelogram.
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The Diagnosis | N-Acetylsulfadiazine crystals
Computed tomography of the abdomen showed multiple
large stones within both kidneys (Figure 1). Antegrade
pyelogram (Figure 2) revealed bilateral filling defects within
the renal pelvis and proximal ureters. Percutaneous nephro-
lithotomy was performed and multiple irregular shaped
stones were extracted (Figure 3). Stone analysis revealed
N-acetylsulfadiazine.
Because of good brain penetration, sulfadiazine is largely
used for the treatment of cerebral toxoplasmosis, most
frequently in a setting of AIDS, organ transplantation, and
other states of immunosupression.1–3 High doses (4–8 g per
day) of sulfadiazine have been associated with intratubular
crystallization of poorly soluble metabolite N-acetylsulfadia-
zine with resulting development of bilateral renal calculi and
acute renal failure. Other factors that provoke formation of
sulfadiazine kidney stones include low urine volume and low
urine pH.1,4,5
Microscopic examination of the urine can show charac-
teristic ‘sheaves of wheat’ crystalluria. The clinical value of
finding N-acetylsulfadiazine crystals is high, as it allows for
early initiation of preventive measures for stone formation,
including hydration and urine alkalanization. Like uric acid
stones, N-acetylsulfadiazine stones are radiolucent and there-
fore, abdominal ultrasonography, computed tomography, or
pyelogram are required for the diagnosis, as opposed to a
plain abdominal radiograph.
Alkalinization of urine and high fluid intake (in excess of
2 l/day) have been generally recommended for patients
during the treatment with high-doses sulfadiazine. In this
particular case, sulfadiazine was discontinued after the
diagnosis of nephrolithiasis was made and changed to
clindamycin.
When severe obstruction is present, ureteral stenting or
nephrostomy placement may become necessary. Bilateral
nephrostomy was performed in this case. Following dis-
continuation of sulfadiazine and urologic intervention, the
patient’s renal function completely recovered and nephro-
lithiasis did not recur.
In conclusion, physicians should be aware that sulfadia-
zine, which is used in the treatment of cerebral toxoplasmosis
can lead to both acute renal failure and nephrolithiasis.
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Figure 3 | Several irregularly shaped calculus fragments
composed of a sulfadiazine metabolite. Each grid division equals
2 mm.
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